A case of lactic acidosis induced by linezolid

Nature Reviews Nephrology

Volumn 6, Issue 4, 2010, Pages 236-242

  Velez, Juan Carlos Q ^a   Janech, Michael G ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DIDANOSINE; GABAPENTIN; HYDROCODONE; ISONIAZID; LAMIVUDINE; LINEZOLID; MEROPENEM; METFORMIN; METOCLOPRAMIDE; METOPROLOL; METRONIDAZOLE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PANTOPRAZOLE; PROPOFOL; PROPYLENE GLYCOL; RNA DIRECTED DNA POLYMERASE INHIBITOR; TETRACYCLINE; ZIDOVUDINE;

ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; BACTEREMIA; CASE REPORT; CHRONIC DRUG ADMINISTRATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; HEMODIALYSIS; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LACTIC ACIDOSIS; MALE; MENTAL HEALTH; METABOLIC ACIDOSIS; NAUSEA; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIDE EFFECT; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ACETAMIDES; ACIDOSIS, LACTIC; ADULT; ANTI-INFECTIVE AGENTS; HUMANS; MALE; OXAZOLIDINONES;

EID: 77950224331     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.20     Document Type: Article

References (36)

1. Palenzuela, L. et al. Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis? Clin. Infect. Dis. 40, e113-e116 (2005).
2. Misbin, R. I. Phenformin-associated lactic acidosis: pathogenesis and treatment. Ann. Intern. Med. 87, 591-595 (1977).
3. Leach, K. L. et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol. Cell. 26, 393-402 (2007).
4. Wilson, D. N. et al. The oxazolidinone antibiotics perturb the ribosomal peptidyltransferase center and effect tRNA positioning. Proc. Natl Acad. Sci. USA 105, 13339-13344 (2008).
5. Thompson, J., O'Connor, M., Mills, J. A. & Dahlberg, A. E. The protein synthesis inhibitors, oxazolidinones and chloramphenicol, cause extensive translational inaccuracy in vivo. J. Mol. Biol. 322, 273-279 (2002).
6. Sharma, M. R. et al. Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins. Cell 115, 97-108 (2003).
7. McKee, E. E., Ferguson, M., Bentley, A. T. & Marks, T. A. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob. Agents Chemother. 50, 2042-2049 (2006).
8. Nagiec, E. E. et al. Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis. Antimicrob. Agents Chemother. 49, 3896-3902 (2005).
9. Soriano, A., Miró, O. & Mensa, J. Mitochondrial toxicity associated with linezolid. N. Engl. J. Med. 353, 2305-2306 (2005).
10. Carson, J., Cerda, J., Chae, J. H., Hirano, M. & Maggiore, P. Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism. Pharmacotherapy 27, 2771-2774 (2007).
11. Naranjo, C. A. et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30, 239-245 (1981).
12. Narita, M., Tsuji, B. T. & yu, V. L. Linezolidassociated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy 27, 1189-1197 (2007).
13. Apodaca, A. A. & Rakita, R. M. Linezolidinduced lactic acidosis. N. Engl. J. Med. 348, 86-87 (2003).
14. Garrabou, G. et al. Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob. Agents Chemother. 51, 962-967 (2007).
15. Thorell, E. A., Sharma, M., Jackson, M. A., Selvarangan, R. & Woods, G. M. Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients. J. Pediatr. Hematol. Oncol. 28, 678-681 (2006).
16. Boutoille, D., Grossi, O., Depatureaux, A. & Tattevin, P. Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrugresistant tuberculosis. Eur. J. Intern. Med. 20, e134-e135 (2009).
17. Fernández de Orueta, L., Díaz, V., Ramírez, M. & Alvarez, R. Linezolid-induced lactic acidosis [Spanish]. Enferm. Infecc. Microbiol. Clin. 27, 550-551 (2009).
18. De Vriese, A. S. et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin. Infect. Dis. 42, 1111-1117 (2006).
19. Bernard, L., Stern, R., Lew, D. & Hoffmeyer, P. Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin. Infect. Dis. 36, 1197 (2003).
20. Bishop, E., Melvani, S., Howden, B. P., Charles, P. G. & Grayson, M. L. Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients. Antimicrob. Agents Chemother. 50, 1599-1602 (2006).
21. Scotton, P. et al. Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis. Infection 36, 387-388 (2008).
22. Wiener, M., Guo, y., Patel, G. & Fries, B. C. Lactic acidosis after treatment with linezolid. Infection 35, 278-281 (2007).
23. Lee, y. R. et al. Early development of lactic acidosis with short term linezolid treatment in a renal recipient. J. Chemother. 20, 766-767 (2008).
24. Kopterides, P., Papadomichelakis, E. & Armaganidis, A. Linezolid use associated with lactic acidosis. Scand. J. Infect. Dis. 37, 153-154 (2005).
25. Pea, F. et al. Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient. Clin. Infect. Dis. 42, 434-435 (2006).
26. Vu, N.-S. D. & Walia, R. Linezolid-induced lactic acidosis [abstract]. Chest 130, 337-338 (2006).
27. Beekmann, S. E., Gilbert, D. N. & Polgreen, P. M. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn. Microbiol. Infect. Dis. 62, 407-410 (2008).
28. Herrnstadt, C. et al. Reduced-median-network analysis of complete mitochondrial DNA codingregion sequences for the major African, Asian, and European haplogroups. Am. J. Hum. Genet. 70, 1152-1171 (2002).
29. Suzuki, T. et al. Structural compensation for the deficit of rRNA with proteins in the mammalian mitochondrial ribosome. Systematic analysis of protein components of the large ribosomal subunit from mammalian mitochondria. J. Biol. Chem. 276, 21724-21736 (2001).
30. Haas, R. H. et al. The in-depth evaluation of suspected mitochondrial disease. Mol. Genet. Metab. 94, 16-37 (2008).
31. Wynalda, M. A., Hauer, M. J. & Wienkers, L. C. Oxidation of the novel oxazolidinone antibiotic linezolid in human liver microsomes. Drug Metab. Dispos. 28, 1014-1017 (2000).
32. Stalker, D. J. & Jungbluth, G. L. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin. Pharmacokinet. 42, 1129-1140 (2003).
33. Brier, M. E. et al. Pharmacokinetics of linezolid in subjects with renal dysfunction. Antimicrob. Agents Chemother. 47, 2775-2780 (2003).
34. Chodock, R. et al. Survival of a human immunodeficiency patient with nucleosideinduced lactic acidosis--role of haemodialysis treatment. Nephrol. Dial. Transplant. 14, 2484-2486 (1999).
35. Roy, P. M., Gouello, J. P., Pennison-Besnier, I. & Chennebault, J. M. Severe lactic acidosis induced by nucleoside analogues in an HIVinfected man. Ann. Emerg. Med. 34, 282-284 (1999).
36. Fiaccadori, E. et al. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure. Crit. Care Med. 32, 2437-2442 (2004).